HR 9297
117th Congress
House
Health
Pre-Approval Information Exchange Act of 2022
Introduced: November 15, 2022
Introduced by:
Guthrie, Brett
Republican
· Kentucky
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 16, 2022
Referred to the Subcommittee on Health.
Nov 15, 2022
Referred to the House Committee on Energy and Commerce.
Nov 15, 2022
Introduced in House
Plain-English summary
Pre-Approval Information Exchange Act of 2022
This bill specifies that product information that is exchanged between drug manufacturers and certain health care entities (e.g., formulary committees) about drug products before regulatory approval is not considered to be misbranding if it relates to the product's investigational use and meets other specified criteria. The Government Accountability Office must study the use and effects of such information.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2